Case Study: Prescribed Drugs with CAMs
A 35-year-old male, Mr. NX, presents to your clinic today with complaints of back pain and “just not feeling good.” Regarding his back, he states that his back pain is a chronic condition that he has suffered with for about the last 10 years. He has not suffered any specific injury to his back. He denies weakness of the lower extremities, denies bowel or bladder changes or dysfunction, and denies radiation of pain to the lower extremities and no numbness or tingling of the lower extremities. He describes the pain as a constant dull ache and tightness across the low back.
He states he started a workout program about 3 weeks ago. He states he is working out with a friend who is a body builder. He states his friend suggested taking Creatine to help build muscle and Coenzyme Q10 as an antioxidant so he started those medications at the same time he began working out. He states he also takes Kava Kava for his anxiety and garlic to help lower his blood pressure.
His historical diagnoses, currently under control, are:
Type II diabetes since age 27
High blood pressure
His prescribed medications include:
Glyburide 3 mg daily with breakfast
Lisinopril 20 mg daily
Coumadin 5 mg daily
*****This Assignment needs to be an APA formatted paper of no more than five (5) pages excluding title page and references.
Based on the above case study, address each section of the Unit 9 Assignment template
Unit 9 Assignment Template:
Case Study: MN553 Advanced Pharmacology
Unit 9 Case Study
“Prescribed Drugs with CAMs”
Date of Submission
This paper addresses a pharmacological management plan for Mr. NX, including consideration of possible contraindications for CAMs, prescriptive, and non-prescriptive recommendations for management of acute pain and other ongoing disease processes, followed by evaluation strategies.
Pharmacological Management Plan
CAMs Contraindicated with Current Prescriptions
CAMs Contraindicated with Diagnoses
Prescription for Back Pain
Changes in Prescribed Drugs
Strategies for Evaluating Side/Adverse Effects
Strategies for Evaluating Effectiveness
Romm, A. (2011). Overprescribing of antibiotics for children’s upper respiratory infections. Alternative options to consider. Alternative and Complementary Therapies, 17(6), 306–309. Retrieved from http://search.ebscohost.com.lib.kaplan.edu/login.a…
Singh, J. A., Furst, D. E., Bharat, A., Curtis, J. R., Kavanaugh, A. F., Kremer, J. M.,…Saag, K. G. (2012). Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. In U.S. Department of Health and Human Services, Agency for Health Research and Quality, National Guideline Clearinghouse. Retrieved from http://www.guideline.gov/content.aspx?id=36892&search=rheumatoid+arthritis